Skip to main content

Former Federal Prosecutor Running For Congress Says Legalize Marijuana To Hurt Cartels

An Oregon campaign to legalize psilocybin mushrooms for therapeutic purposes is within striking distance to qualify for the state’s November ballot. But with a deadline to submit signatures fast approaching, activists announced on Monday that they will be taking new steps to ensure success.

So far, organizers have collected more than 130,000 signatures for Initiative Petition 34, which would make Oregon the first jurisdiction in the U.S. to implement a therapeutic legalization model for the psychedelic. While that raw total is more than is required, the signatures haven’t been certified by the state and the campaign is aiming to collect an additional 15,000 signatures as a buffer against invalid submissions ahead of the July 2 deadline.

Tom Eckert, one of the chief petitioners behind the measure, said in a press release that the COVID-19 outbreak will likely exacerbate mental health issues that the initiative aims to address, demonstrating the need for the campaign to push ahead and develop alternative strategies to gather additional signatures.

“The stressors associated with the pandemic will undoubtedly push [rates of mental illness] even higher, which further highlights the importance of this initiative,” he said. “The pandemic also presents real challenges for our campaign in collecting the remaining signatures we need to make the ballot in November. Thankfully, our networks and supporters are energized and mobilizing—they understand what is at stake here, and we’re counting on that enthusiasm to overcome the obstacles we face.”

While in-person signature collection is no longer a viable option during a time of coronavirus social distancing and stay-at-home orders, the campaign will be hosting group video chat organizing calls, orchestrating texting and social media communications and calling prospective voters on the phone. The aim is to encourage residents to fill out petitions and mail them in to organizers.

The Yes On IP 34 campaign shared some social media plugs in an email blast on Sunday, touting mentions from authors Michael Pollan and Tim Ferriss, as well as the wellness company Dr. Bronner’s, which is also providing funding for the initiative, as well as several others across the country.

Water Avenue Coffee also rolled out a special blend, dubbed River Trip, and a portion of the proceeds from its sales will be donated to the campaign.

“Qualifying for the November ballot will require a concerted effort from a broad base of volunteers and partners, as well as from Oregon voters who will have to step up and put a little more time in than would typically be necessary to sign this petition,” Sheri Eckert, another chief petitioner, said. “We’ve been working for years to build a formidable coalition of healthcare professionals, veterans, and advocates of all kinds who believe that this psilocybin therapy initiative offers an important therapeutic option for many Oregonians and we will not let the current challenges discourage our efforts.”

Activists initially announced that the campaign had been impacted by the pandemic last month. It appears to have gathered an additional 2,000 signatures since then.

“The Oregon initiative is so critically important. It’s time to create the structures within society for safely using psilocybin in a responsible manner for maximum benefit, as this is a uniquely powerful tool for healing,” mycologist Paul Stamets, who sits on the campaign’s board, said.

A separate campaign in the state that’s backing a measure to decriminalize drug possession and increase substance misuse treatment said last month that is has gathered enough raw signatures to qualify for the ballot, though those signatures have yet to be validated and advocates similarly hope to collect more in the weeks to come.

Across the U.S., drug policy reform campaigns are feeling the sting of the coronavirus outbreak.

California activists for a campaign to amend the state’s legal cannabis program also requested a digital signature option since in-person collection is not possible. A separate effort to put psilocybin legalization on the state ballot ended last week after activists failing to meet a signature deadline.

In Washington, D.C., advocates for a measure to decriminalize psychedelics asked the mayor and local lawmakers to accept online signatures for their ballot petition.

An effort to legalize medical cannabis in Nebraska is facing similar signature gathering challenges. And in Missouri, an adult-use marijuana legalization campaign is officially over for the year due to the health crisis.

Idaho activists announced that they are suspending their ballot campaign to legalize medical cannabis, though they are still “focusing on distributing petitions through online download at IdahoCann.co and encouraging every volunteer who has downloaded a petition to get them turned in to their county clerk’s office by mail, regardless of how many signatures they have collected.”

In Arizona, a legalization campaign is petitioning the state Supreme Court to instruct the secretary of state to allow individuals to sign ballot petitions digitally using an existing electronic system that is currently reserved for individual candidates seeking public office.

North Dakota advocates said earlier this month that they are suspending their campaign to put marijuana legalization on the November ballot due to the coronavirus outbreak.

Montana advocates filed a lawsuit against the state last month, urging officials to allow electronic signature gathering for a measure to legalize marijuana for adult use. State officials filed a response opposing the request last week.

In New York, Gov. Andrew Cuomo (D) conceded that the legalization push in the legislature is “effectively over” for 2020. He also said that the policy change may prove too complicated for lawmakers to take up remotely via video conferencing.

Top Montana Officials Oppose Marijuana Campaign’s Lawsuit For Electronic Signature Gathering

Photo courtesy of Wikimedia/Mushroom Observer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Original Article Source: https://www.marijuanamoment.net/former-federal-prosecutor-running-for-congress-says-legalize-marijuana-to-hurt-cartels/

Comments

Post a Comment

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...
Post a Comment
Read more

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...
Post a Comment
Read more